The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 336:872-873 March 20, 1997 Number 12
NextNext

Birth Outcomes in Pregnant Women Taking Fluoxetine

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
 by Chambers, C. D.
-PubMed Citation
To the Editor: Chambers et al. (Oct. 3 issue)1 report birth outcomes after prenatal exposure to fluoxetine but fail to provide results for infants of mothers with mood disorders who were not treated or who received other antidepressant drugs. Although their findings of similar rates of major malformations in fluoxetine-exposed infants and unexposed infants are consistent with previous reports,2 the findings of higher rates of perinatal complications after third-trimester exposure to fluoxetine are not.3

The authors propose that the occurrence of three minor malformations in a single infant is a marker for embryonic disruption and, specifically, central nervous system disruption. . . . [Full Text of this Article]

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.